ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Metabolomic Profiles of Hepatocellular Carcinoma and Cirrhotic Patients Before and After Transplantation.

C. Desai,1 R. Varghese,2 S. Robertazzi,1 C. Di Poto,2 A. Ferrarini,2 C. Tu,2 R. Girlanda,1 K. Khan,1 T. Fishbein,1 H. Ressom.2

1Medstar Georgetown Transplant institute, Washington DC
2Department of Oncology, Lombardi Comprehensive Cancer Center, Washington DC.

Meeting: 2016 American Transplant Congress

Abstract number: A194

Keywords: Hepatocellular carcinoma, Liver metabolism, Liver transplantation

Session Information

Session Name: Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies

Session Type: Poster Session

Date: Saturday, June 11, 2016

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Metabolomics offers the opportunity to characterize complex diseases like hepatocellular carcinoma (HCC) through a systematic evaluation of thousands of metabolites in human liver tissues and fluids. In this study, we compared the metabolomic profiles of HCC and cirrhotic patients before and after liver transplant. This was accomplished by untargeted analysis of plasma samples using gas chromatography coupled with mass spectrometry (GC-MS). Plasma samples from 12 patients (6 HCC cases and 6 patients with liver cirrhosis) were collected before and after transplant. The participants were frequency-matched by physiological variables. After protein depletion, metabolites were extracted from the plasma samples. The metabolite extracts were then derivatized before GC-MS data acquisition. The raw GC-MS data were preprocessed by performing outlier screening, peak detection and deconvolution, retention index calibration, alignment, and metabolite identification by NIST and Fiehn library search. A total of 736 analytes have been detected for further statistical analysis. A repeated measures ANOVA model with mixed effects was used to evaluate multiple comparisons among and within HCC and cirrhotic groups. 43 metabolites were selected as statistically significant with adjusted p-value < 0.05. Out of these, 22 metabolites have putative identifications. It was observed that the post-transplant profiles for HCC and cirrhotic patients were very similar. In a previous biomarker study conducted using plasma samples from HCC cases and cirrhotic controls prior to liver transplant, our team found significant changes in the levels of citric acid, L-glutamic acid, L-Tyrosine, L-Threonine, L-Phenylalanine, L-leucine, and D-Fructose. Interestingly, in the present study, we observed that these metabolites have changed significantly after transplant. A pathway analysis using Ingenuity Pathway Analysis tool revealed that tRNA charging pathway is enriched in both HCC and cirrhotic patients, after transplant.

CITATION INFORMATION: Desai C, Varghese R, Robertazzi S, Di Poto C, Ferrarini A, Tu C, Girlanda R, Khan K, Fishbein T, Ressom H. Metabolomic Profiles of Hepatocellular Carcinoma and Cirrhotic Patients Before and After Transplantation. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Desai C, Varghese R, Robertazzi S, Poto CDi, Ferrarini A, Tu C, Girlanda R, Khan K, Fishbein T, Ressom H. Metabolomic Profiles of Hepatocellular Carcinoma and Cirrhotic Patients Before and After Transplantation. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/metabolomic-profiles-of-hepatocellular-carcinoma-and-cirrhotic-patients-before-and-after-transplantation/. Accessed May 9, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences